The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in Alzheimer’s patients.
The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in Alzheimer’s patients.
Comments